Dr. Saini is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5501 Hopkins Bayview Circle
Asthma and Allergy Center
Baltimore, MD 21224Phone+1 410-550-2300Fax+1 410-550-3256- Is this information wrong?
Summary
- Dr. Sarbjit Saini is an allergist/immunologist in Baltimore, MD and is affiliated with multiple hospitals in the area, including Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center. He received his medical degree from The Ohio State University College of Medicine and has been in practice 26 years.
Education & Training
- Johns Hopkins UniversityFellowship, Allergy and Immunology, 1994 - 1997
- University of Michigan Health SystemResidency, Internal Medicine, 1991 - 1994
- Ohio State University College of MedicineClass of 1991
Certifications & Licensure
- FL State Medical License 2020 - Present
- MD State Medical License 1995 - 2025
- MI State Medical License 1993 - 1997
- American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Effect of Anti-IgE in Chronic Urticaria Start of enrollment: 2004 Nov 01
- Omalizumab in the Treatment of Peanut Allergy Start of enrollment: 2009 Jul 01
- The Effects of Omalizumab (Anti-IgE) on the Late-phase Response to Nasal Allergen Challenge Start of enrollment: 2009 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Efficacy and Safety of Systemic Corticosteroids for Urticaria: A systematic review and meta-analysis of randomized clinical trials.Xiajing Chu, Jason Wang, Leonardo Ologundudu, Romina Brignardello-Petersen, Gordon H Guyatt, Paul Oykhman, Jonathan A Bernstein, Sarbjit S Saini, Lisa A Beck, Susan Wa...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2024 Apr 18
- Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials.Marcus Maurer, Thomas B Casale, Sarbjit S Saini, Moshe Ben-Shoshan, Ana M Giménez-Arnau, Jonathan A Bernstein, Akiko Yagami, Aleksandra Stjepanovic, Allen Radin, Herib...> ;The Journal of Allergy and Clinical Immunology. 2024 Feb 29
- Functional human skin explants as tools for assessing mast cell activation and inhibition.Clarence Rachel Villanueva, Keane Barksdale, Tinuola Owolabi, Donavan Bridges, Kristin Chichester, Sarbjit Saini, Eric T Oliver> ;Frontiers in Allergy. 2024 Jan 1
- Join now to see all
Other
- Chronic urticaria: Clinical manifestations, diagnosis, pathogenesis, and natural historySaini S
http://www.uptodate.com/contents/chronic-urticaria-clinical-manifestations-diagnosis-pathogenesis-an
UpToDate, Wolters Kluwer Health - 2013-01-28
Press Mentions
- Novel BTK Inhibitor for Chronic Hives Wins in Phase III TrialNovember 16th, 2023
Hospital Affiliations
- Johns Hopkins HospitalBaltimore, Maryland
- Johns Hopkins Bayview Medical CenterBaltimore, Maryland
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/sarbjit-saini
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: